OMPI of America - Stevanato Group

OMPI of America - Stevanato Group
Share

OMPI of America - Stevanato Group

 •  December 23, 2017

The commercial hub will provide bulk and sterile glass primary packaging to the Japanese market further strengthening ties with local customers.
Stevanato Group, through Ompi, its specialist in glass primary packaging for the pharmaceutical industry, opens a commercial office in Nagoya, Japan, the third biggest pharmaceutical market in the world*....

OMPI of America - Stevanato Group

 •  November 23, 2017

The company will serve the growing domestic and South American pharmaceutical industry with high quality glass ampoules, cartridges and vials
Stevanato Group, the global producer of systems, process and services for the pharmaceutical industry, inaugurates today at the presence of local authorities and customers, its newest factory in Sete Lagoas...

OMPI of America - Stevanato Group

 •  October 23, 2017

Piombino Dese, Padua - Ompi widens its product portfolio launching LDP (Low Delamination Propensity) Vials. In addition to the flexibility offered by the Ez-fill® portfolio, LDP Vials have the advantage of a minimized delamination propensity reducing the risk of drug product recalls to pharmaceutical companies.
The delamination of pharmaceutical...

Pharmaceutical customers will benefit from a breakthrough in pharmaceutical glass technology while patients will access safer medicines and vaccines.
Stevanato Group and Corning Incorporated (NYSE: GLW) are entering a new collaboration agreement focused on supplying Corning Valor™ Glass for storage and delivery of high quality parenteral packaging...

The recent licensee partnership agreement with Gerresheimer reaffirms Ompi EZ-fill as the reference sterile process technology able to minimize pharma and biotech companies’ total cost of ownership.
Ompi, the company within Stevanato Group specialized in glass primary packaging for the pharmaceutical industry, has signed a license agreement with...